A new analysis indicates that certain characteristics may increase a breast cancer survivor's risk of developing leukemia after undergoing chemotherapy and/or radiation the findings are a first. Abstract: breast cancer is the second most common cancer in the world and the most common cancer among women in this retrospective study data regarding demographic characteristics and treatment outcome was collected from all breast cancer patients for a period of 15 years more than 50% of patients were diagnosed at a later stage.
Breast cancer characteristics if, based on the test results, your doctors determine that the abnormality is breast cancer, they will look at a wide range of factors in considering the most effective course of treatment. Dosing characteristics appear important for successful treatment of breast cancer longer treatment, higher cumulative doses of anthracyclines and taxanes, and the addition of capecitabine and trastuzumab are associated with better response.
Studies interpret this result as meaning higher comorbidity, diagnosis at later stages of the disease, and less effective treatment in the elderly the aim of this study is to evaluate the diagnosis and treatment characteristics of breast cancer and their effect on the survival of women aged 65 and above. High levels of her2/neu often mean that a tumor is more aggressive, and may respond differently to certain cancer treatments for example, women with high levels of her2/neu may be good candidates for certain biological therapies learn more about biological therapies in breast cancer treatment.
To analyze the characteristics and outcomes of women with breast cancer in the northern alberta health region (nahr) who declined recommended primary standard treatments a chart review was performed of breast cancer patients who refused recommended treatments during the period 1980 to 2006. Traditionally, all patients with breast cancer have been treated in a similar fashion, and breast cancer was treated as a single disease increasingly, the heterogeneity of breast malignancies is being recognized and encompasses many factors, including hormone receptor expression, variable patterns of gene expression, and varying histologic appearance.
Germline brca1 mutations were an independent predictor of breast cancer mortality in multivariate analysis (hazard ratio 24, 95% confidence interval 12–48 p = 001) brca1 status predicted breast cancer mortality only among women who did not receive chemotherapy (hazard ratio 48, 95% confidence interval 20–117 p = 0001. Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the national cancer data base christopher m pezzi, md,1 lina patel-parekh, mha, che,2 karin cole, md,1 jan.
Neoadjuvant treatment of breast cancer: the use of hormone therapy to treat breast cancer before surgery (neoadjuvant therapy) has been studied in clinical trials the goal of neoadjuvant therapy is to reduce the size of a breast tumor to allow breast-conserving surgery. Background: to analyze the characteristics and outcomes of women with breast cancer in the northern alberta health region (nahr) who declined recommended primary standard treatments methods: a chart review was performed of breast cancer patients who refused recommended treatments during the period 1980 to 2006.
After a median follow-up period of 116 months, breast cancer specific survival was worse in women with brca1 mutations than in those without (62% at 10 years versus 86% p the brca2 mutation (84% versus 86% at 10 years p = 076.